| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | NuvaRing | FAERS: 3 | US FAERS | |
| 2 | Venlafaxine Hydrochloride | FAERS: 3 | US FAERS | |
| 3 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 4 | Isotretinoin | FAERS: 2 | US FAERS | |
| 5 | Citalopram | FAERS: 1 | US FAERS | |
| 6 | Fluoxetine | FAERS: 1 | US FAERS | |
| 7 | Haloperidol | FAERS: 1 | US FAERS | |
| 8 | Ibuprofen | FAERS: 1 | US FAERS | |
| 9 | Pregabalin | FAERS: 1 | US FAERS | |
| 10 | Risperidone | FAERS: 1 | US FAERS | |
| 11 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 12 | tetrahydrozoline | FAERS: 1 | US FAERS | |
| 13 | tofacitinib | FAERS: 1 | US FAERS | |
| 14 | Darunavir | OFFSIDES | ||
| 15 | Tretinoin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.